» Articles » PMID: 34516144

Reversibly Modulating the Blood-Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles

Abstract

The blood-brain barrier (BBB) is highly selective and acts as the interface between the central nervous system and circulation. While the BBB is critical for maintaining brain homeostasis, it represents a formidable challenge for drug delivery. Here we synthesized gold nanoparticles (AuNPs) for targeting the tight junction specifically and demonstrated that transcranial picosecond laser stimulation of these AuNPs post intravenous injection increases the BBB permeability. The BBB permeability change can be graded by laser intensity, is entirely reversible, and involves increased paracellular diffusion. BBB modulation does not lead to significant disruption in the spontaneous vasomotion or the structure of the neurovascular unit. This strategy allows the entry of immunoglobulins and viral gene therapy vectors, as well as cargo-laden liposomes. We anticipate this nanotechnology to be useful for tissue regions that are accessible to light or fiberoptic application and to open new avenues for drug screening and therapeutic interventions in the central nervous system.

Citing Articles

Advances in primary large B-cell lymphoma of immune-privileged sites.

Wang L, Guo M, Hou S Front Immunol. 2025; 16:1533444.

PMID: 40078990 PMC: 11896999. DOI: 10.3389/fimmu.2025.1533444.


Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system.

Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.

PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.


Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier.

Liang K, Yang L, Kang J, Liu B, Zhang D, Wang L Asian J Pharm Sci. 2024; 19(6):100963.

PMID: 39640059 PMC: 11616058. DOI: 10.1016/j.ajps.2024.100963.


Engineering extracellular vesicles to transiently permeabilize the blood-brain barrier.

Tomatis F, Rosa S, Simoes S, Barao M, Jesus C, Novo J J Nanobiotechnology. 2024; 22(1):747.

PMID: 39623431 PMC: 11613868. DOI: 10.1186/s12951-024-03019-w.


Emerging trends in virus and virus-like particle gene therapy delivery to the brain.

Mandalawatta H, Rajendra K, Fairfax K, Hewitt A Mol Ther Nucleic Acids. 2024; 35(3):102280.

PMID: 39206077 PMC: 11350507. DOI: 10.1016/j.omtn.2024.102280.


References
1.
Chow B, Nunez V, Kaplan L, Granger A, Bistrong K, Zucker H . Caveolae in CNS arterioles mediate neurovascular coupling. Nature. 2020; 579(7797):106-110. PMC: 7060132. DOI: 10.1038/s41586-020-2026-1. View

2.
Gao Z, Ye H, Tang D, Tao J, Habibi S, Minerick A . Platinum-Decorated Gold Nanoparticles with Dual Functionalities for Ultrasensitive Colorimetric in Vitro Diagnostics. Nano Lett. 2017; 17(9):5572-5579. DOI: 10.1021/acs.nanolett.7b02385. View

3.
Bazzoni G, Dejana E . Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004; 84(3):869-901. DOI: 10.1152/physrev.00035.2003. View

4.
Rezai A, Ranjan M, DHaese P, Haut M, Carpenter J, Najib U . Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. Proc Natl Acad Sci U S A. 2020; 117(17):9180-9182. PMC: 7196825. DOI: 10.1073/pnas.2002571117. View

5.
Pardridge W . Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012; 32(11):1959-72. PMC: 3494002. DOI: 10.1038/jcbfm.2012.126. View